2021 Jun Pietro Ghezzi, Kevin V Lemley, James P Andrus, Stephen C De Rosa, Arne Holmgren, Dean Jones, Farook Jahoor, Richard Kopke, Ian Cotgreave, Teodoro Bottiglieri, Neil Kaplowitz, Hajime Nakamura, Frank Staal, Stephen W Ela, Kondala R Atkuri, Rabindra Tirouvanziam, Kartoosh Heydari, Bita Sahaf, Andrew Zolopa, Richard Eugene Frye, John J Mantovani, Leonard A Herzenberg, Leonore A Herzenberg
10.1038/onc.2010.236 Oncogene 140 WilhelmS.CarterC.LynchM.LowingerT.DumasJ.SmithR
Experts say there could be a large cohort of patients who have not benefited from semaglutide or tirzepatide but retatrutide may work on them
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by identifying predispositions in key pathwaysincluding GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 variantsthat relate to how your body responds to GLP-1 agonists